Literature DB >> 17052278

A case-control study of risk factors for hepatitis C infection in patients with unexplained routes of infection.

M Karmochkine1, F Carrat, O Dos Santos, P Cacoub, G Raguin.   

Abstract

Twenty to 40% of hepatitis C virus (HCV)-infected patients do not have a recognized parenteral risk factor, suggesting that still-unidentified modes of transmission exist. In order to investigate potential routes of HCV transmission for patients with no recognized parenteral risk factor, we conducted a multicentre case-control study. A total of 450 HCV-seropositive patients with no history of transfusion or intravenous drug use and 757 controls were recruited from the general population and matched for sex, age, geographical residence and number of chronic diseases. All subjects answered an interviewer-administered questionnaire on potential risk factors for HCV. Eighty per cent of cases had chronic hepatitis or cirrhosis. Respective percentages of genotypes 1, 2, 3, 4 and 5 were 65, 14, 11, 5 and 4. Among the 66 items considered, multivariate analysis identified 15 independent risk factors for HCV infection: nosocomial [admission to medical (odds ratio, OR = 2.1) or surgical ward (OR = 1.7), digestive endoscopy (OR = 1.9), abortion (OR = 1.7)], outpatient treatments [cutaneous ulcer and wound care (OR = 10.1), diathermy (OR = 3.0), gamma globulin (OR = 1.7), intravenous (OR = 1.7) or intramuscular (OR = 1.4) injections, varicose vein sclerotherapy (OR = 1.6), acupuncture (OR = 1.5)] and lifestyle-associated [intranasal cocaine use (OR = 4.5), practice of contact sports (OR = 2.3), beauty treatments (OR = 2.0), professional pedicure/manicure (OR = 1.7)]. These factors could explain 73% of community-acquired hepatitis C. In conclusion, for patients with unexplained routes of HCV infection, our data incriminate previously unidentified risk factors (abortions, some dermatological procedures, outpatient injections, contact sports, beauty treatments, professional pedicure/manicure) and confirm those already recognized (hospitalization, digestive endoscopy, acupuncture and intranasal cocaine use).

Entities:  

Mesh:

Year:  2006        PMID: 17052278     DOI: 10.1111/j.1365-2893.2006.00742.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  33 in total

Review 1.  Hepatocellular carcinoma: A global view.

Authors:  Ju Dong Yang; Lewis R Roberts
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-07-13       Impact factor: 46.802

2.  Hepatitis C Virus Infection Caused by Infrequent Exposure in China Should Be of Concern.

Authors:  Xin-Cheng Qin; Li-Hua Zhong; Li-Ying Zhu; Alexander Plyusnin; Yong-Zhen Zhang
Journal:  Virol Sin       Date:  2020-02-21       Impact factor: 4.327

Review 3.  Transmission of hepatitis C virus infection through tattooing and piercing: a critical review.

Authors:  Rania A Tohme; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2012-01-30       Impact factor: 9.079

4.  Prevalence of HCV risk behaviors among prison inmates: tattooing and injection drug use.

Authors:  Marisol Peña-Orellana; Adriana Hernández-Viver; Glorimar Caraballo-Correa; Carmen E Albizu-García
Journal:  J Health Care Poor Underserved       Date:  2011-08

5.  Co-infection by hepatitis C virus in HIV-infected patients in southern Brazil: genotype distribution and clinical correlates.

Authors:  Fernando H Wolff; Sandra C Fuchs; Nêmora N T Barcellos; Paulo Ricardo de Alencastro; Maria Letícia R Ikeda; Ajácio B M Brandão; Maicon Falavigna; Flávio D Fuchs
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

6.  Social networks shape the transmission dynamics of hepatitis C virus.

Authors:  Camila Malta Romano; Isabel M V Guedes de Carvalho-Mello; Leda F Jamal; Fernando Lucas de Melo; Atila Iamarino; Marco Motoki; João Renato Rebello Pinho; Edward C Holmes; Paolo Marinho de Andrade Zanotto
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

7.  Clinicopathological features and genotype distribution in patients with hepatitis C virus chronic liver disease.

Authors:  Rachel Abraham; Banumathi Ramakrishna; Avinash Balekuduru; Hubert Darius J Daniel; Priya Abraham; C Eapen Eapen; George Kurian
Journal:  Indian J Gastroenterol       Date:  2009-08-21

Review 8.  Epidemiology of hepatitis C in Croatia in the European context.

Authors:  Tatjana Vilibic-Cavlek; Jasmina Kucinar; Bernard Kaic; Maja Vilibic; Nenad Pandak; Ljubo Barbic; Vladimir Stevanovic; Jasmina Vranes
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

9.  A 25-year study of the clinical and histologic outcomes of hepatitis C virus infection and its modes of transmission in a cohort of initially asymptomatic blood donors.

Authors:  Robert D Allison; Cathy Conry-Cantilena; Deloris Koziol; Cathy Schechterly; Paul Ness; Joan Gibble; David E Kleiner; Marc G Ghany; Harvey J Alter
Journal:  J Infect Dis       Date:  2012-06-27       Impact factor: 5.226

10.  Injection drug use is a risk factor for HCV infection in urban Egypt.

Authors:  Adela Paez Jimenez; Mostafa K Mohamed; Noha Sharaf Eldin; Hasnaa Abou Seif; Said El Aidi; Yehia Sultan; Nasr Elsaid; Claire Rekacewicz; Mostafa El-Hoseiny; May El-Daly; Mohamed Abdel-Hamid; Arnaud Fontanet
Journal:  PLoS One       Date:  2009-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.